Dr. Dinesh Vyas to Join Panel at LSI Europe ’25
We’re excited to announce that Dr. Dinesh Vyas, CEO and Founder of StaplCam and HydroLap, will be speaking on a featured panel at the LSI Europe ’25 Emerging MedTech Summit, taking place in London from September 7–11, 2025.
LSI Europe is one of the leading global conferences connecting medtech innovators, investors, and healthcare leaders, focused on scaling transformative medical technologies.
Event & Session Details
Session Title: Adoption vs Value: Getting Ready to Scale
Time: 11:15 AM – 11:55 AM
Date: See full agenda
Location: London, UK
Panelists include:
Eliane Schutte, CEO, Xeltis
Fabio Bambang Oetomo, CEO, Bambi Medical
Jos Lunenberg, CEO, Surfix Diagnostics
About Dr. Dinesh Vyas
Surgical Innovator & MedTech Entrepreneur
Dr. Dinesh Vyas is an internationally recognized surgeon, researcher, and medtech entrepreneur, known for developing breakthrough technologies in minimally invasive and robotic surgery. He has founded and led multiple companies focused on improving surgical efficiency, access, and patient outcomes.
StaplCam
StaplCam is the world’s first fully disposable, single-incision robotic surgical platform. It integrates a stapler, grasper, and dual-camera system with a built-in digital display—designed to simplify workflows, reduce operating room complexity, and expand global access to advanced surgery.
HydroLap
HydroLap is a next-generation water-powered surgical device engineered for precision and control in high-volume surgeries. By leveraging fluid dynamics, HydroLap helps reduce tissue trauma, improve visualization, and optimize efficiency in the operating room—particularly in outpatient and ASC settings.
Global Leadership & Academic Impact
Beyond his role as CEO, Dr. Vyas has served as:
Associate Dean of Surgical Research
Program Director for Surgical Residency
Chair of Innovation, Research & Quality
He has authored 100+ peer-reviewed publications, holds 15+ patents, and is widely recognized for his pioneering work in robotic gastrointestinal surgery, trauma education, and medical device innovation.
Why This Panel Matters
The session “Adoption vs Value: Getting Ready to Scale” addresses one of the most critical challenges in medtech today: how to successfully scale innovation while proving real clinical and commercial value.
Dr. Vyas brings a rare, firsthand perspective from building and leading two disruptive surgical technology companies, offering insights into:
Scaling breakthrough surgical devices from concept to adoption
Building value propositions that resonate with clinicians, health systems, and investors
Navigating regulatory, clinical, and operational hurdles in medtech commercialization
This panel is a must-attend for medtech founders, investors, surgeons, and healthcare leaders interested in how next-generation surgical technologies are shaping the future of care.
